心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2020 ESC共识文件：心肌细胞老化和心肌保护

2020-05-08 欧洲心脏病学会 Cardiovasc Res. 2020 May 8.

心肌心肌细胞

2020年5月，欧洲心脏病学会(ESC)发布了心肌细胞老化和心肌保护共识文件，高龄是影响冠脉综合征和共病状态心脏保护性干预应答的主要易感因素。此外，高龄也显著增加缺血/再灌注（IR）损伤后进展为缺血后

中文标题：

2020 ESC共识文件：心肌细胞老化和心肌保护

英文标题：

Cardiomyocyte ageing and cardioprotection: Consensus Document from the ESC Working Groups Cell Biology of the Heart and Myocardial Function.

发布机构：

欧洲心脏病学会

发布日期：

2020-05-08

简要介绍：

2020年5月，欧洲心脏病学会(ESC)发布了心肌细胞老化和心肌保护共识文件，高龄是影响冠脉综合征和共病状态心脏保护性干预应答的主要易感因素。此外，高龄也显著增加缺血/再灌注（IR）损伤后进展为缺血后不良重塑和心力衰竭的风险。本文主要综述了当前心肌细胞老化和心肌保护的最新知识。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESC共识文件：心肌细胞老化和心肌保护.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d94fd1c001905ae5, title=2020 ESC共识文件：心肌细胞老化和心肌保护 , enTitle=Cardiomyocyte ageing and cardioprotection: Consensus Document from the ESC Working Groups Cell Biology of the Heart and Myocardial Function., guiderFrom=Cardiovasc Res. 2020 May 8., authorId=0, author=, summary=2020年5月，欧洲心脏病学会(ESC)发布了心肌细胞老化和心肌保护共识文件，高龄是影响冠脉综合征和共病状态心脏保护性干预应答的主要易感因素。此外，高龄也显著增加缺血/再灌注（IR）损伤后进展为缺血后, cover=https://img.medsci.cn/2020517/1589724947408_2020535.jpg, journalId=0, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会，会员超过70000人、提供更新指南、调查数据、组织学术会议，ESC年会是心血管领域最大的会议。下设5个分会（超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会）。提供指南较全面，按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Fri May 08 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年5月，欧洲心脏病学会(ESC)发布了心肌细胞老化和心肌保护共识文件，高龄是影响冠脉综合征和共病状态心脏保护性干预应答的主要易感因素。此外，高龄也显著增加缺血/再灌注（IR）损伤后进展为缺血后不良重塑和心力衰竭的风险。本文主要综述了当前心肌细胞老化和心肌保护的最新知识。</p> </div> </div> </div>, tagList=[TagDto(tagId=353, tagName=心肌), TagDto(tagId=3809, tagName=心肌细胞)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3809, guiderKeyword=心肌细胞, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2491, appHits=198, showAppHits=191, pcHits=661, showPcHits=2509, likes=0, shares=7, comments=9, approvalStatus=1, publishedTime=Sun May 17 23:03:59 CST 2020, publishedTimeString=2020-05-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun May 17 22:15:50 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 03:00:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESC共识文件：心肌细胞老化和心肌保护.pdf)])
2020 ESC共识文件：心肌细胞老化和心肌保护.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051842, encodeId=3bb21051842f5, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=368487940, createdName=zjw, createdTime=Thu Sep 16 11:04:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907953, encodeId=aafc90e95396, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb625438935, createdName=ms7000001209868210, createdTime=Mon Dec 14 20:56:30 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889959, encodeId=e3fc889959b9, content=只能在这里打开看吗，还能分享到第三方软件去查看吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200701/6326a3f3cd0c475bb88ae6adcbee31b6/922746697ae44795804dce0cdbfd3b23.jpg, createdBy=f0ac5397403, createdName=咩子, createdTime=Sat Oct 03 20:51:16 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804092, encodeId=956d8040924c, content=这个软件好好用呀 可以搜到最新的指南 支持！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/6c985ac9a8b64717b899a2b5931f0ba0/5f40c636aafd4af59cb56b6987ac53e9.jpg, createdBy=6ccc5402354, createdName=ms2000000630457342, createdTime=Thu Jul 23 12:36:49 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469145, encodeId=9c9b46914509, content=123456, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c5f5310731, createdName=2274981184_12398311, createdTime=Thu May 21 22:57:34 CST 2020, time=2020-05-21, status=1, ipAttribution=)]
    2021-09-16 zjw

    学习下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051842, encodeId=3bb21051842f5, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=368487940, createdName=zjw, createdTime=Thu Sep 16 11:04:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907953, encodeId=aafc90e95396, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb625438935, createdName=ms7000001209868210, createdTime=Mon Dec 14 20:56:30 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889959, encodeId=e3fc889959b9, content=只能在这里打开看吗，还能分享到第三方软件去查看吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200701/6326a3f3cd0c475bb88ae6adcbee31b6/922746697ae44795804dce0cdbfd3b23.jpg, createdBy=f0ac5397403, createdName=咩子, createdTime=Sat Oct 03 20:51:16 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804092, encodeId=956d8040924c, content=这个软件好好用呀 可以搜到最新的指南 支持！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/6c985ac9a8b64717b899a2b5931f0ba0/5f40c636aafd4af59cb56b6987ac53e9.jpg, createdBy=6ccc5402354, createdName=ms2000000630457342, createdTime=Thu Jul 23 12:36:49 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469145, encodeId=9c9b46914509, content=123456, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c5f5310731, createdName=2274981184_12398311, createdTime=Thu May 21 22:57:34 CST 2020, time=2020-05-21, status=1, ipAttribution=)]
    2020-12-14 ms7000001209868210

    学到了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051842, encodeId=3bb21051842f5, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=368487940, createdName=zjw, createdTime=Thu Sep 16 11:04:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907953, encodeId=aafc90e95396, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb625438935, createdName=ms7000001209868210, createdTime=Mon Dec 14 20:56:30 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889959, encodeId=e3fc889959b9, content=只能在这里打开看吗，还能分享到第三方软件去查看吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200701/6326a3f3cd0c475bb88ae6adcbee31b6/922746697ae44795804dce0cdbfd3b23.jpg, createdBy=f0ac5397403, createdName=咩子, createdTime=Sat Oct 03 20:51:16 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804092, encodeId=956d8040924c, content=这个软件好好用呀 可以搜到最新的指南 支持！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/6c985ac9a8b64717b899a2b5931f0ba0/5f40c636aafd4af59cb56b6987ac53e9.jpg, createdBy=6ccc5402354, createdName=ms2000000630457342, createdTime=Thu Jul 23 12:36:49 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469145, encodeId=9c9b46914509, content=123456, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c5f5310731, createdName=2274981184_12398311, createdTime=Thu May 21 22:57:34 CST 2020, time=2020-05-21, status=1, ipAttribution=)]
    2020-10-03 咩子

    只能在这里打开看吗，还能分享到第三方软件去查看吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051842, encodeId=3bb21051842f5, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=368487940, createdName=zjw, createdTime=Thu Sep 16 11:04:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907953, encodeId=aafc90e95396, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb625438935, createdName=ms7000001209868210, createdTime=Mon Dec 14 20:56:30 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889959, encodeId=e3fc889959b9, content=只能在这里打开看吗，还能分享到第三方软件去查看吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200701/6326a3f3cd0c475bb88ae6adcbee31b6/922746697ae44795804dce0cdbfd3b23.jpg, createdBy=f0ac5397403, createdName=咩子, createdTime=Sat Oct 03 20:51:16 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804092, encodeId=956d8040924c, content=这个软件好好用呀 可以搜到最新的指南 支持！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/6c985ac9a8b64717b899a2b5931f0ba0/5f40c636aafd4af59cb56b6987ac53e9.jpg, createdBy=6ccc5402354, createdName=ms2000000630457342, createdTime=Thu Jul 23 12:36:49 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469145, encodeId=9c9b46914509, content=123456, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c5f5310731, createdName=2274981184_12398311, createdTime=Thu May 21 22:57:34 CST 2020, time=2020-05-21, status=1, ipAttribution=)]
    2020-07-23 ms2000000630457342

    这个软件好好用呀 可以搜到最新的指南 支持！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1051842, encodeId=3bb21051842f5, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=368487940, createdName=zjw, createdTime=Thu Sep 16 11:04:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907953, encodeId=aafc90e95396, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb625438935, createdName=ms7000001209868210, createdTime=Mon Dec 14 20:56:30 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889959, encodeId=e3fc889959b9, content=只能在这里打开看吗，还能分享到第三方软件去查看吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200701/6326a3f3cd0c475bb88ae6adcbee31b6/922746697ae44795804dce0cdbfd3b23.jpg, createdBy=f0ac5397403, createdName=咩子, createdTime=Sat Oct 03 20:51:16 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804092, encodeId=956d8040924c, content=这个软件好好用呀 可以搜到最新的指南 支持！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/6c985ac9a8b64717b899a2b5931f0ba0/5f40c636aafd4af59cb56b6987ac53e9.jpg, createdBy=6ccc5402354, createdName=ms2000000630457342, createdTime=Thu Jul 23 12:36:49 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469145, encodeId=9c9b46914509, content=123456, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c5f5310731, createdName=2274981184_12398311, createdTime=Thu May 21 22:57:34 CST 2020, time=2020-05-21, status=1, ipAttribution=)]
    2020-05-21 2274981184_12398311

    123456

    1

    展开1条回复

相关指南

2019 SCCT专家共识：心肌CT灌注成像

美国心血管计算机断层扫描学会(SCCT,Society of Cardiovascular Computed Tomography) · 2019-12-11

2015 ACP建议：应用心电图、超声心动图或心肌灌注成像进行心脏检查

美国医师协会(ACP,American College of Physicians) · 2015-03-17